Eolus AB Class B

As of June 30, 2026, Eolus AB Class B carries a market capitalization of 1.08B, placing it among publicly traded companies globally. Its enterprise value stands at 938.05M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Eolus AB Class B's next confirmed earnings release is scheduled for November 13, 2026.

As of June 30, 2026, Eolus AB Class B has 24.87M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.49, and the price-to-book ratio stands at 0.84.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.42 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 938.05M versus a market cap of 1.08B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Eolus AB Class B maintains a current ratio of 10.33, meaning it holds 10.3x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Eolus AB Class B posted a negative return on equity (ROE) of -20.35, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -11.98, reflecting losses generated across the asset base. The company generates approximately 19.39M in revenue per employee across its workforce of 114.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.50 indicates how many times Eolus AB Class B sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Eolus AB Class B recorded an income tax benefit of -17.00M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -322.00M and -294.00M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Eolus AB Class B's stock has gained approximately 7.20% over the past 52 weeks. The 50-day moving average sits at 47.62, while the 200-day moving average is 41.32.

Over the twelve months ended June 30, 2026, Eolus AB Class B generated 2.22B in revenue and converted that into -294.00M in net income, yielding earnings per share of -12.32. EBITDA reached -211.00M, while operating income came in at -258.00M.

As of June 30, 2026, Eolus AB Class B holds 706.00M in cash and equivalents against 495.00M in total debt, resulting in a net debt position of -227.00M. Total book value stands at 1.28B, with working capital of 1.79B providing operational flexibility.

Eolus AB Class B produced 901.00M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -3.00M in capital expenditures, free cash flow totaled 898.00M - equivalent to 36.15 per share.

Over the twelve months ended June 30, 2026, Eolus AB Class B posted a gross margin of 1.85, reflecting its pricing power and cost economics. The operating margin of -11.65 and net profit margin of -13.27 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Eolus AB Class B paid dividends of 1.49 per share. The dividend payout ratio of -11.64 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 83.38, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 38.12, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Eolus AB Class B shareholders.

As of June 30, 2026, Eolus AB Class B has an Altman Z-Score of 3.33, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.